Crossover Study to Assess the Efficacy and Safety of UX007 in the Treatment of Movement Disorders Associated With Glucose Transporter Type 1 Deficiency Syndrome (Glut1 DS)
Clinical trial NCT02960217 · TERMINATED
Trial details
- NCT number
- NCT02960217
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-19
- Primary completion
- 2019-10-09
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.